bonyf Advances to Phase 3 in the Development of Al

bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream
|| || |Clinical Study Confirms Exceptional Performance and High Tolerability| |Knokke-Heist (Belgium), 8 April 2025, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), a leader in dental consumer goods and professional dental consumables, announces that it has successfully advanced to Phase 3 in the development of its innovative Alginate-Organic Olive-oil based Denture Fixative Cream following a positive clinical-dermatological application study conducted by Dermatest GmbH (Germany).| |The study assessed the product’s efficacy and safety after daily application over five consecutive days by healthy denture wearers.| |The primary objective of the study was to evaluate the retention, stability, and functional benefits of the Alginate-Organic Olive-oil based Denture Fixative Cream while also investigating its tolerability according to stringent clinical-dermatological test criteria.| |The results were highly encouraging, demonstrating that Alginate-Organic Olive-oil based Denture Fixative Cream significantly improves masticatory ability and provides long-lasting retention for upper dentures, with holding times of up to 24 hours when applied according to instructions.| |Additionally, the study confirmed the excellent tolerability of the product. All participants completed the five-day application period without experiencing any adverse reactions, such as irritation or allergic responses.| |These findings underscore the unique positioning of bonyf’s Alginate-Organic Olive-oil based Denture Fixative Cream as a superior solution in the market—offering both extended hold performance and a healthy, organic-based formulation.| |*“The successful outcome of this study is a significant milestone for bonyf, as we continue our mission to develop cutting-edge solutions that enhance the well-being of denture wearers”*, said CEO, Jean-Pierre Bogaert.| |bonyf remains committed to innovation and plans to accelerate preparations for market launch, with Alginate-Organic Olive-oil based Denture Fixative Cream poised to set a new standard in denture care.| |For more information, visit bonyf.com or contact investor@bonyf.com.| |bonyf’s strengths Products with patented formulations Produced in Switzerland compliant with stringent international quality regulations Proven clinical efficacy Commercial presence in 37 countries Prospects for solid growth and rapid profitability A fast-growing oral and dental care market | || |About bonyf Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market. For more information about bonyf and its innovative oral care products, please visit www.bonyf.com. | |bonyf Jean-Pierre Bogaert investor@bonyf.com|